Today’s medicine maintains as 2 separate medical fields metabolic cardiovascular disorders (MCVDs) and major psychiatric disorders (MPDs) such as schizophrenia, bipolar disorder, and depression. Yet MCVD and MPD can affect the same patient, and they may share common genetic, environmental, and developmental roots. Confronting these facts innovatively may have unforeseen clinical and research significance.
Article InformationCorresponding Author: Michel Maziade, MD, Centre de Recherche, Institut Universitaire en Santé Mentale de Québec 2601, Chemin de la Canardière, F-4500, Québec City, QC G1J 2G3, Canada (firstname.lastname@example.org).
Published Online: November 4, 2013. doi:10.1001/jamapediatrics.2013.3871.
Conflict of Interest Disclosures: Dr Maziade has been consultant for GlaxoSmithKline and Eli Lilly and has received research funding from GlaxoSmithKline, Eli Lilly, and AstraZeneca that are not related to this article. No other disclosures are reported.
Funding/Support: This work was supported by a Canada Research Chair (950-200810) in psychiatric genetics of which Dr Maziade is the Chair, by Canadian Institute of Health Research grants (MOP-74430, MOP-114988, and MOP-119408).
Role of the Sponsor: The funders had no role in the preparation, review, or approval of the manuscript.